SYDNEY, Aug. 6, 2025 /PRNewswire/ -- A revolutionary new brain health assessment platform, ScreenIT, has officially launched, marking a major step forward in how...
SOUTH SAN FRANCISCO, July 25, 2025 (GLOBE NEWSWIRE) -- Recognify Life Sciences, a clinical-stage biotech company focused on developing treatments for cognitive impairment, today announced that its randomized, double-blind, placebo-controlled Phase 2b clinical trial evaluating inidascamine (formerly RL-007) in patients with cognitive impairment associated with schizophrenia (CIAS) did not meet its primary endpoint.
Over $100,000 in financial and technology grants awarded globally to support educators and innovation
NEW YORK, July 1, 2025 /PRNewswire/ -- Echo360, the global leader in transformative...
KnowBe4 releases Program Maturity Assessment tool that measures and strengthens an organization’s security culture across critical human risk dimensions
KnowBe4 releases Program Maturity Assessment tool that measures and strengthens an organization’s security culture across critical human risk dimensions
KnowBe4 releases Program Maturity Assessment tool that measures and strengthens an organization’s security culture across critical human risk dimensions
KnowBe4 releases Program Maturity Assessment tool that measures and strengthens an organization’s security culture across critical human risk dimensions